Lanean...
Histone Deacetylase 6 as a Therapeutic Target in B cell-associated Hematological Malignancies
B lymphocytes play a critical role in humoral immunity. Abnormal B cell development and function cause a variety of hematological malignancies such as myeloma, B cell lymphoma, and leukemia. Histone deacetylase 6 (HDAC6) inhibitors alone or in combination with other drugs have shown efficacy in seve...
Gorde:
| Argitaratua izan da: | Front Pharmacol |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Frontiers Media S.A.
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7333221/ https://ncbi.nlm.nih.gov/pubmed/32676030 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.00971 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|